CITADEL ADVISORS LLC historic quarter change: USA Bonds: Other Debt, Reduced
In other debt filed by principal amount (debentures, bonds) (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 884 positions, added to 1,270, reduced 1,104 and sold out of 996.
- Q3 2018: Stock LIGAND PHARMACEUTICALS INC; Country of operation —; Class Bond; Principal before $69,000,000.
- Q3 2018: Stock MOLINA HEALTHCARE INC; Country of operation —; Class Bond; Principal before $94,250,000.
- Q3 2018: Stock INTEL CORP; Country of operation —; Class Bond; Principal before $27,000,000.
- Q3 2018: Stock MICROCHIP TECHNOLOGY INC; Country of operation —; Class Bond; Principal before $83,100,000.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.
| Quarter | Stock | Country of operation | Class | Principal before | Principal after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2018 | LIGAND PHARMACEUTICALS INC
CUSIP 53220KAD0 | — | Bond | $69,000,000 | $17,000,000 | -52,000,000 | $189,807 | $62,311 | -$127,496 | 2018-11-13 |
|---|
| Q3 2018 | MOLINA HEALTHCARE INC
CUSIP 60855RAC4 | — | Bond | $94,250,000 | $33,697,000 | -60,553,000 | $228,080 | $122,996 | -$105,084 | 2018-11-13 |
|---|
| Q3 2018 | INTEL CORP
CUSIP 458140AF7 | — | Bond | $27,000,000 | $12,000,000 | -15,000,000 | $64,712 | $27,546 | -$37,166 | 2018-11-13 |
|---|
| Q3 2018 | MICROCHIP TECHNOLOGY INC
CUSIP 595017AF1 | — | Bond | $83,100,000 | $75,100,000 | -8,000,000 | $97,679 | $79,979 | -$17,700 | 2018-11-13 |
|---|
| Q3 2018 | TESARO INC
CUSIP 881569AA5 | — | Bond | $20,000,000 | $11,500,000 | -8,500,000 | $29,899 | $15,332 | -$14,567 | 2018-11-13 |
|---|
| Q3 2018 | APOLLO COML REAL EST FIN INC
CUSIP 03762UAA3 | — | Bond | $20,500,000 | $7,436,000 | -13,064,000 | $21,898 | $8,229 | -$13,669 | 2018-11-13 |
|---|
| Q3 2018 | MEDICINES CO
CUSIP 584688AE5 | — | Bond | $38,175,000 | $30,968,000 | -7,207,000 | $46,384 | $33,310 | -$13,074 | 2018-11-13 |
|---|
| Q3 2018 | ENCORE CAP GROUP INC
CUSIP 292554AH5 | — | Bond | $29,676,000 | $16,676,000 | -13,000,000 | $27,440 | $15,577 | -$11,863 | 2018-11-13 |
|---|
| Q3 2018 | VECTOR GROUP LTD
CUSIP 92240MBC1 | — | Bond | $47,799,000 | $37,494,000 | -10,305,000 | $50,754 | $39,140 | -$11,614 | 2018-11-13 |
|---|
| Q3 2018 | PTC THERAPEUTICS INC
CUSIP 69366JAB7 | — | Bond | $19,300,000 | $7,000,000 | -12,300,000 | $19,172 | $8,067 | -$11,105 | 2018-11-13 |
|---|
| Q3 2018 | TEVA PHARMACEUTICAL FIN LLC
CUSIP 88163VAE9 | — | Bond | $16,000,000 | $6,600,000 | -9,400,000 | $14,835 | $6,198 | -$8,637 | 2018-11-13 |
|---|
| Q3 2018 | MICROCHIP TECHNOLOGY INC
CUSIP 595017AH7 | — | Bond | $32,160,000 | $28,160,000 | -4,000,000 | $38,263 | $29,716 | -$8,547 | 2018-11-13 |
|---|
| Q3 2018 | MEDICINES CO
CUSIP 584688AG0 | — | Bond | $43,019,000 | $38,019,000 | -5,000,000 | $43,170 | $34,792 | -$8,378 | 2018-11-13 |
|---|
| Q3 2018 | RENEWABLE ENERGY GROUP INC
CUSIP 75972AAC7 | — | Bond | $11,500,000 | $4,575,000 | -6,925,000 | $20,544 | $12,493 | -$8,051 | 2018-11-13 |
|---|
| Q3 2018 | INTERCEPT PHARMACEUTICALS IN
CUSIP 45845PAA6 | — | Bond | $15,500,000 | $6,000,000 | -9,500,000 | $13,596 | $6,050 | -$7,546 | 2018-11-13 |
|---|
| Q3 2018 | CHESAPEAKE ENERGY CORP
CUSIP 165167CY1 | — | Bond | $13,000,000 | $6,000,000 | -7,000,000 | $13,260 | $5,919 | -$7,341 | 2018-11-13 |
|---|
| Q3 2018 | DERMIRA INC
CUSIP 24983LAB0 | — | Bond | $20,200,000 | $13,612,000 | -6,588,000 | $16,648 | $11,348 | -$5,300 | 2018-11-13 |
|---|
| Q3 2018 | NEW MTN FIN CORP
CUSIP 647551AB6 | — | Bond | $28,165,000 | $23,355,000 | -4,810,000 | $28,576 | $23,577 | -$4,999 | 2018-11-13 |
|---|
| Q3 2018 | SILVER STD RES INC
CUSIP 82823LAC0 | — | Bond | $34,850,000 | $30,000,000 | -4,850,000 | $34,503 | $29,598 | -$4,905 | 2018-11-13 |
|---|
| Q3 2018 | BLACKROCK TCP CAPITAL CORP
CUSIP 87238QAD5 | — | Bond | $15,000,000 | $10,500,000 | -4,500,000 | $15,000 | $10,495 | -$4,505 | 2018-11-13 |
|---|
| Q3 2018 | ECHO GLOBAL LOGISTICS INC
CUSIP 27875TAA9 | — | Bond | $24,997,000 | $20,878,000 | -4,119,000 | $26,055 | $21,864 | -$4,191 | 2018-11-13 |
|---|
| Q3 2018 | COLONY STARWOOD HOMES
CUSIP 19625XAB8 | — | Bond | $24,669,000 | $22,044,000 | -2,625,000 | $27,596 | $24,296 | -$3,300 | 2018-11-13 |
|---|
| Q3 2018 | CSG SYS INTL INC
CUSIP 126349AF6 | — | Bond | $9,000,000 | $6,000,000 | -3,000,000 | $9,490 | $6,329 | -$3,161 | 2018-11-13 |
|---|
| Q3 2018 | ELECTRONICS FOR IMAGING INC
CUSIP 286082AC6 | — | Bond | $15,500,000 | $12,500,000 | -3,000,000 | $15,383 | $12,339 | -$3,044 | 2018-11-13 |
|---|
| Q3 2018 | OSI SYSTEMS INC
CUSIP 671044AD7 | — | Bond | $12,150,000 | $9,400,000 | -2,750,000 | $11,789 | $9,005 | -$2,784 | 2018-11-13 |
|---|
| Q3 2018 | ASCENT CAP GROUP INC
CUSIP 043632AA6 | — | Bond | $15,086,000 | $9,086,000 | -6,000,000 | $8,825 | $6,309 | -$2,516 | 2018-11-13 |
|---|
| Q3 2018 | ALDER BIOPHARMACEUTICALS INC
CUSIP 014339AA3 | — | Bond | $27,000,000 | $24,000,000 | -3,000,000 | $28,182 | $25,836 | -$2,346 | 2018-11-13 |
|---|
| Q3 2018 | TIMKENSTEEL CORP
CUSIP 887399AA1 | — | Bond | $7,500,000 | $6,500,000 | -1,000,000 | $11,570 | $9,286 | -$2,284 | 2018-11-13 |
|---|
| Q3 2018 | AEGEAN MARINE PETE NETWORK I
CUSIP 00773VAB2 | — | Bond | $6,000,000 | $500,000 | -5,500,000 | $1,944 | $293 | -$1,651 | 2018-11-13 |
|---|
| Q3 2018 | REALPAGE INC
CUSIP 75606NAB5 | — | Bond | $9,000,000 | $7,000,000 | -2,000,000 | $12,775 | $11,442 | -$1,333 | 2018-11-13 |
|---|
| Q3 2018 | K2M GROUP HLDGS INC
CUSIP 48273JAB3 | — | Bond | $15,000,000 | $13,000,000 | -2,000,000 | $19,041 | $17,727 | -$1,314 | 2018-11-13 |
|---|
| Q3 2018 | STARWOOD WAYPOINT RESIDENTL
CUSIP 85571WAB5 | — | Bond | $36,975,000 | $36,645,000 | -330,000 | $46,709 | $45,832 | -$877 | 2018-11-13 |
|---|
| Q3 2018 | NUVASIVE INC
CUSIP 670704AG0 | — | Bond | $30,363,000 | $25,354,000 | -5,009,000 | $32,947 | $32,124 | -$823 | 2018-11-13 |
|---|
| Q3 2018 | WRIGHT MED GROUP N V
CUSIP 98236JAB4 | — | Bond | $56,500,000 | $52,000,000 | -4,500,000 | $75,584 | $75,252 | -$332 | 2018-11-13 |
|---|
| Q3 2018 | HCI GROUP INC
CUSIP 40416EAD5 | — | Bond | $42,175,000 | $41,675,000 | -500,000 | $41,205 | $41,492 | +$287 | 2018-11-13 |
|---|
| Q3 2018 | BLACKROCK TCP CAPITAL CORP
CUSIP 87238QAB9 | — | Bond | $4,000,000 | $3,850,000 | -150,000 | $4,074 | $3,906 | -$168 | 2018-11-13 |
|---|
| Q3 2018 | YANDEX NV
CUSIP 98474TAB3 | — | Bond | $15,500,000 | $15,354,000 | -146,000 | $15,281 | $15,244 | -$37 | 2018-11-13 |
|---|